Search results summary

From Health Canada

New search

Search criteria

  • Status: Select all
  • AIG: 0150422001

Search results

List of returned drug products
Products returned by the search are listed, including their status, DIN number, name, class, total count of active ingredients and the name of one, etc. Clicking on the value in the DIN column returns more complete information about the related product.
Status DIN Company Product Class PM See footnote1 Schedule # See footnote2 A.I. name See footnote3 Strength
Marketed 02553805 CELLTRION INC. OMLYCLO Human Yes SCHEDULE D 1 OMALIZUMAB 75 MG / 0.5 ML
Marketed 02553805 CELLTRION INC. OMLYCLO Human Yes PRESCRIPTION 1 OMALIZUMAB 75 MG / 0.5 ML
Marketed 02553813 CELLTRION INC. OMLYCLO Human Yes PRESCRIPTION 1 OMALIZUMAB 150 MG / 1 ML
Marketed 02553813 CELLTRION INC. OMLYCLO Human Yes SCHEDULE D 1 OMALIZUMAB 150 MG / 1 ML
Marketed 02561018 CELLTRION INC. OMLYCLO Human Yes PRESCRIPTION 1 OMALIZUMAB 75 MG / 0.5 ML
Marketed 02561018 CELLTRION INC. OMLYCLO Human Yes SCHEDULE D 1 OMALIZUMAB 75 MG / 0.5 ML
Marketed 02561026 CELLTRION INC. OMLYCLO Human Yes SCHEDULE D 1 OMALIZUMAB 150 MG / 1 ML
Marketed 02561026 CELLTRION INC. OMLYCLO Human Yes PRESCRIPTION 1 OMALIZUMAB 150 MG / 1 ML
Approved 02565013 CELLTRION INC. OMLYCLO Human Yes PRESCRIPTION 1 OMALIZUMAB 300 MG / 2 ML
Approved 02565013 CELLTRION INC. OMLYCLO Human Yes SCHEDULE D 1 OMALIZUMAB 300 MG / 2 ML
Approved 02565021 CELLTRION INC. OMLYCLO Human Yes PRESCRIPTION 1 OMALIZUMAB 300 MG / 2 ML
Approved 02565021 CELLTRION INC. OMLYCLO Human Yes SCHEDULE D 1 OMALIZUMAB 300 MG / 2 ML
Marketed 02260565 NOVARTIS PHARMACEUTICALS CANADA INC XOLAIR Human Yes SCHEDULE D 1 OMALIZUMAB 150 MG / VIAL
Marketed 02260565 NOVARTIS PHARMACEUTICALS CANADA INC XOLAIR Human Yes PRESCRIPTION 1 OMALIZUMAB 150 MG / VIAL
Marketed 02459787 NOVARTIS PHARMACEUTICALS CANADA INC XOLAIR Human Yes PRESCRIPTION 1 OMALIZUMAB 75 MG / 0.5 ML
Marketed 02459787 NOVARTIS PHARMACEUTICALS CANADA INC XOLAIR Human Yes SCHEDULE D 1 OMALIZUMAB 75 MG / 0.5 ML
Marketed 02459795 NOVARTIS PHARMACEUTICALS CANADA INC XOLAIR Human Yes SCHEDULE D 1 OMALIZUMAB 150 MG / 1 ML
Marketed 02459795 NOVARTIS PHARMACEUTICALS CANADA INC XOLAIR Human Yes PRESCRIPTION 1 OMALIZUMAB 150 MG / 1 ML
Marketed 02545136 NOVARTIS PHARMACEUTICALS CANADA INC XOLAIR Human Yes SCHEDULE D 1 OMALIZUMAB 75 MG / 0.5 ML
Marketed 02545136 NOVARTIS PHARMACEUTICALS CANADA INC XOLAIR Human Yes PRESCRIPTION 1 OMALIZUMAB 75 MG / 0.5 ML
Marketed 02545144 NOVARTIS PHARMACEUTICALS CANADA INC XOLAIR Human Yes SCHEDULE D 1 OMALIZUMAB 150 MG / 1 ML
Marketed 02545144 NOVARTIS PHARMACEUTICALS CANADA INC XOLAIR Human Yes PRESCRIPTION 1 OMALIZUMAB 150 MG / 1 ML
Approved 02545152 NOVARTIS PHARMACEUTICALS CANADA INC XOLAIR Human Yes PRESCRIPTION 1 OMALIZUMAB 300 MG / 2 ML
Approved 02545152 NOVARTIS PHARMACEUTICALS CANADA INC XOLAIR Human Yes SCHEDULE D 1 OMALIZUMAB 300 MG / 2 ML
Marketed 02545160 NOVARTIS PHARMACEUTICALS CANADA INC XOLAIR Human Yes PRESCRIPTION 1 OMALIZUMAB 300 MG / 2 ML
Marketed 02545160 NOVARTIS PHARMACEUTICALS CANADA INC XOLAIR Human Yes SCHEDULE D 1 OMALIZUMAB 300 MG / 2 ML
New search

Application information

Related information

Contact us

Version 4.0.4

"Page details"

Date modified: